Exclusive enteral nutrition initiates individual protective microbiome changes to induce remission in pediatric Crohn′s disease
Deborah Haecker,Kolja Siebert,Byron J Smith,Nikolai Koehler,Alessandra Riva,Aritra Mahapatra,Helena Heimes,Jiatong Nie,Amira Metwaly,Hannes L Hoelz,Quirin Manz,Federica De Zen,Jeannine Heetmeyer,Katharina Socas,Le Thi Giang,Chen Meng,Karin Kleigrewe,Josch K Pauling,Klaus Neuhaus,Markus List,Katherine S Pollard,Tobias Schwerd,Dirk Haller
DOI: https://doi.org/10.1101/2023.12.21.23300351
2024-09-16
Abstract:Exclusive enteral nutrition (EEN) is the first-line therapy for pediatric Crohn′s disease (CD), but protective mechanisms remain unknown. We established a prospective pediatric cohort to characterize the function of fecal microbiota and metabolite changes of treatment-naïve CD patients in response to EEN. Integrated multi-omics analysis identified network clusters from individually variable microbiome profiles, with Lachnospiraceae and medium chain fatty acids as protective features. Bioorthogonal non-canonical amino acid tagging selectively identified bacterial species in response to medium chain fatty acids. Metagenomic analysis identified high strain-level dynamics in response to EEN. Functional changes of diet-exposed fecal microbiota were further validated in a combined approach using gut chemostat cultures and microbiota transfer into germ-free Il10-deficient mice. Dietary model conditions induced individual patient-specific strain signatures to prevent or cause IBD-like inflammation in gnotobiotic mice. Hence, we provide evidence that EEN therapy operates through explicit functional changes of temporally and individually variable microbiome profiles.